Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox for complex anal fistula after seton drainage
ACTRN12620000094976Phase 3Recruiting
- Sponsor
- Deakin University
- Start
- Jun 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in anal fistula, sponsored by Deakin University. Started Jun 2020; status: recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
anal fistula
Beyond the preview
Go deeper on ACTRN12620000094976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12620000094976.